Kuwait to receive Japanese COVID-19 drug next week

The use of the drug will be in accordance to Japanese guidelines, World Health Organization’s recommendations, and Kuwait’s regulations. (File/AFP)

• The antiviral medication Faviporavir, sold under the brand name Avigan, has shown promising results after clinical trials

DUBAI: Kuwait’s Health Ministry said the first batch of Avigan, a Japanese medicine that showed positive results in treating coronavirus patients, will arrive in the country next week, local daily Arab Times has reported.
The antiviral medication Faviporavir, sold under the brand name Avigan, has shown promising results after clinical trials on coronavirus cases, according to the minister.
“This first shipment of the medication comes as part of assistance for emergency response and humanitarian purposes. It has no commercial aspect from the Japanese government,” Dr Abdullah Al Badr, the Kuwaiti Health Ministry’s assistant undersecretary for medication affairs, said in a statement.
The use of the drug will be in accordance to Japanese guidelines, World Health Organization’s recommendations, and Kuwait’s regulations.